Veteran Marijuana Advocate Steve Fox Leaves NCIA To Join Upstart MJ Trade Group

Longtime marijuana advocate Steve Fox has left the National Cannabis Industry Association, which he co-founded, to join the upstart Cannabis Trade Federation to promote federal MJ reform.

“It is a larger lobbying team at CTF with a lot of reach into a lot of different offices,” Fox told Marijuana Business Daily.

“And, from the perspective of someone who’s been trying to change federal laws actively since 2002, the opportunity to work with so many people to try to end this battle was too good … to turn down.”

CTF recently announced it was hiring 15 Washington DC-based lobbyists to work on passing the States Act, which would exempt cannabis businesses operating in accordance with state law from the federal Controlled Substances Act.

“We’re putting a full-court press on to try to get that passed during this session,” Fox said.

As a strategic adviser, Fox will be working as a consultant for CTF based in Washington DC.

CTF was formed in April 2018 through the merger of the New Federalism Fund and the American Trade Association of Cannabis and Hemp.

Fox co-founded NCIA in 2010 and worked with the group for eight years. He took an expanded role eight months ago as a strategic adviser to NCIA’s DC efforts.

“This is isn’t any reflection of my feelings about NCIA as an organization or anything like that,” Fox said of his move to CTF. “I completely value my time that I spent with the organization.”

Original Article Source: https://mjbizdaily.com/veteran-marijuana-advocate-steve-fox-leaves-ncia-to-join-upstart-mj-trade-group/

Comments

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...

Cannabis Watch: Canopy Growth To Book Charge Of Up To $568 Million As Marijuana Restructuring Continues

Canopy Growth Corp. said early Thursday it was halting a range of operations across three continents and expects its restructuring plans to result in a charge of up to C$800 million (567.9 million) in the fiscal fourth quarter. U.S.-traded shares US:CGC CA:WEED of the cannabis company fell 1.9% in afternoon trading. Canopy said it was selling operations in Africa, curtailing cultivation of hemp in the U.S. and Columbia, and shutting down an indoor production facility in Canada. The announcement will result in 85 job cuts, the company said. “When I arrived at Canopy Growth in January, I committed to conducting a strategic review in order to lower our cost structure and reduce our cash burn,” Canopy Chief Executive David Klein said in a statement. Read: As cannabis industry stays largely quiet on coronavirus, this CEO has been sounding the alarm Canopy’s restructuring announcement was expected by investors, Cowen analyst Vivien Azer wrote in a note to clients Thursday. Azer rate...

Can Medical Marijuana Help Aging Parents With Dementia?

For decades, marijuana, even for medical uses, was demonized or questioned. When states like Colorado legalized it for recreational use, more studies began to determine provable efficacy for its use as a medicine. The Federal government still classifies marijuana the same way it classifies heroin: harmful and with no medical benefits. Now we can see that this is wrong. When states legalized marijuana, referred to as cannabis here, they had an interest in getting data to see what good it could do. Proving efficacy could increase medical marijuana sales, benefit people who might at least find some medical use, and overall would bring tax dollars into the state coffers. Without funding studies, the Federal government has done very little to demonstrate what good cannabis can do. After all, if the presumption is that it helps nothing, there would be no motivation to determine with scientific data that it does anyone any good. But we have convincing data now about its beneficial use ...

Norma Pence

Search This Blog